|
M.V. Putilina
POTENTIALS FOR THE PREVENTIVE THERAPY OF NEUROLOGICAL MANIFESTATIONS OF CHRONIC CEREBRAL ISCHEMIA IN THERAPEUTICAL PRACTICE
|
№7 / 2014
|
|
O.A. Shavlovskaya
THERAPY OF ASTHENIC DISORDERS IN STROKE PATIENTS
|
№19 / 2013
|
|
R.B. Bektoshev, M. Ergashev, O. Bektoshev
ANTIHYPOXANT THERAPY IN THE COMPLEX PATHOGENETICAL TREATMENT OF DEGENERATIVE SPINE DISEASES
|
№18 / 2013
|
|
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS
|
№16 / 2013
|
|
A.A. Fedorovich, A.G.Bagdasaryan, I.G. Uchkin, A.M. Zudin
DISORDERS OF MICROCIRCULATION IN THE SKIN AGAINST THE BACKGROUND OF DISEASES OF THE PERIPHERAL VASCULATURE (SUMMARY)
|
№12 / 2013
|
|
V.Yu.Bogachyov
TOPICAL TREATMENT OF CHRONIC VEIN DISEASES
|
№10 / 2013
|
|
A.M. Shilov
ANTIHYPOXANTS AND ANTIOXIDANTS (ACTOVEGIN) IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR COMPLICATIONS
|
№9 / 2013
|
|
E.A.Katunina
VASCULAR COGNITIVE IMPAIRMENTS AND POTENTIALS FOR THEIR CORRECTION
|
№7 / 2013
|
|
Yu.A. Starchina
Neuroprotective Therapy In The Clinical Practice
|
№14 / 2012
|
|
V.N. Obolensky 1, V.G. Nikitin 2, P.Sh. Leval 1, D.A. Ermolova 2, A.Yu. Molochnikov 1, A.A. Ermolov 2
Pharmacotherapy, Local And Other Methods Of Treatment For Diabetic Foot Syndrome
|
№10 / 2012
|
|
Florian Buchmayer, Johannes Pleiner, Martin W. Elmlinger, Gereon Lauer, Gertfried Nell, Harald H. Sitte
Actovegin: Biological Substance With Semicentennial History*
|
№6 / 2012
|
|
N.V. Matveev
Evaluation Of The Clinical And Economic Efficiency Of Pharmacotherapy Of Diabetic Polyneuropathy
|
№19 / 2011
|
Русский
